The bodybuilding aesthetician

Atopic eczema (atopic dermatitis) is a chronic, intensely itchy inflammatory skin condition. Although it often appears as dry, irritated skin, it is not just a problem of dryness. Instead, eczema reflects a complex interaction between a weakened skin barrier, an overactive immune system within the skin, genetic susceptibility, microbes, and environmental triggers. Together, these factors create a cycle of inflammation, itch, and skin damage.

This is a particularly interesting topic covered during my Level 6 Skin Science studies and my Level 9 in Skin Anatomy. It is also something I have encountered in real life, both personally and professionally. My own little girl experienced eczema as a baby, and I frequently come across eczema when treating clients’ skin and when teaching about facials. Seeing the condition from scientific, clinical, and parental perspectives highlights just how complex and impactful it can be.

How the Skin’s Immune System Is Involved

Eczema is driven by a specific immune pattern dominated by type-2 immune responses. In affected skin, immune cells such as type-2 helper T cells (Th2) and innate lymphoid cells release signaling molecules called cytokines, especially IL-4, IL-5, IL-13, and IL-31.

These cytokines have several harmful effects:

• They weaken the skin’s protective barrier
• They reduce natural antimicrobial defenses
• They promote inflammation
• They intensify itch

Additional cytokines, including IL-4, IL-13, and IL-22, directly suppress key structural proteins that maintain skin integrity, such as filaggrin and claudin-1. As these proteins decline, the barrier becomes leaky, allowing water to escape and irritants, allergens, and microbes to enter more easily.

Innate immune cells including dendritic cells, mast cells, and innate lymphoid cells further amplify inflammation. Skin microbes also play a major role. In particular, overgrowth of Staphylococcus aureus is common in eczema and can worsen inflammation while increasing infection risk.

Key Causes and Triggers

Eczema develops when several biological and environmental factors combine.

Genetic Factors

Genetics strongly influence susceptibility. Mutations affecting filaggrin, a protein essential for maintaining the outer skin barrier, are among the most powerful known risk factors. Other genes involved in immune regulation, particularly those controlling type-2 inflammation, also contribute.

Skin-Barrier Defects

The outer layer of skin in eczema is structurally compromised. This leads to:

• Dryness due to water loss
• Reduced protective lipids and proteins
• Increased penetration of irritants and allergens
• Damage from scratching, which further weakens the barrier

Immune Dysregulation

The immune system in eczema is skewed toward a type-2 inflammatory profile. Elevated cytokines such as IL-4, IL-13, IL-31, and IL-22 sustain chronic inflammation and itch, perpetuating the disease cycle.

Environmental Factors

External triggers vary between individuals but commonly include:

• Irritants such as soaps, detergents, and certain fabrics
• Allergens
• Microbial exposure
• Psychological stress
• Complex gene–environment interactions

These influences can trigger flare-ups in genetically susceptible individuals.

Main Treatment Approaches

Effective management targets both barrier repair and immune overactivity.

Basic Skin Care

Daily use of emollients and barrier-repair moisturizers is the foundation of treatment. These products help restore hydration, protect against irritants, and reduce flare frequency. Identifying and avoiding personal triggers is equally important.

Topical Anti-Inflammatory Treatments

Medicated creams and ointments are used to control active inflammation:

• Topical corticosteroids of appropriate potency
• Calcineurin inhibitors such as tacrolimus and pimecrolimus
• Newer topical JAK inhibitors including ruxolitinib and delgocitinib

When used appropriately, these treatments are effective and generally safe.

Systemic and Advanced Therapies

Moderate to severe eczema may require treatments that act throughout the body.

Conventional immunosuppressants include cyclosporine, methotrexate, azathioprine, and mycophenolate.

Targeted biologic therapies specifically block type-2 immune pathways, including agents that inhibit IL-4 and IL-13 signaling and treatments targeting the IL-31 itch pathway.

Oral JAK inhibitors interfere with intracellular signaling that drives inflammation.

Adjunctive Therapies

Additional treatments may include ultraviolet phototherapy, antimicrobial treatment for secondary infections, and psychological support or structured education programs.

Genetic Factors in Atopic Eczema

Atopic eczema is highly heritable. Studies of twins estimate that genetics account for roughly 70 to 80 percent of risk.

Family Risk

Family history is the strongest predictor. If both parents have eczema, a child’s risk may increase up to fivefold.

Skin-Barrier Genes

Genes involved in maintaining the physical barrier of the skin play a central role.

The most important is the filaggrin gene (FLG). Loss-of-function mutations weaken the outer skin layer, leading to dryness and easier penetration of irritants and allergens. Other barrier-related genes regulate processes such as protease activity, corneocyte cohesion, and tight junction integrity, all of which influence barrier strength.

Immune-Response Genes

Many genetic risk regions affect immune regulation, particularly pathways that promote type-2 inflammation. These include genes involved in cytokine signaling, T-cell activation, IgE responses, and innate host defense.

Large genetic studies have identified dozens of risk loci, most related to immune function and a smaller number related to barrier biology.

Epigenetic and Gene–Environment Effects

Gene activity can also be modified without changing DNA sequence. Environmental factors such as pollution, infections, and lifestyle influences can alter gene expression through mechanisms like DNA methylation and microRNAs.

Many eczema-related genes overlap with those involved in asthma and allergic rhinitis, helping explain the progression known as the atopic march, where individuals develop multiple allergic conditions over time.

Take-Home Message

Eczema is not simply dry skin. It is a complex immune-mediated condition involving a weakened skin barrier, genetic susceptibility, and environmental triggers. Consistent barrier care, appropriate anti-inflammatory treatment when needed, trigger awareness, and education are key to control. Many children improve with time, and informed management can greatly improve comfort, sleep, skin health, and overall quality of lifep.

Disclaimer

This article is for educational purposes only and does not replace medical advice, diagnosis, or treatment. If you or your child has eczema or worsening skin symptoms, consult a qualified healthcare professional for personalised care.

For evidence-based health, fitness, and skin information, follow @sarahcurranfitpro on Instagram.